Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kevin Lillehei to Immunotherapy

This is a "connection" page, showing publications Kevin Lillehei has written about Immunotherapy.

 
Connection Strength
 
 
 
0.655
 
  1. Liu Y, Wang Q, Kleinschmidt-DeMasters BK, Franzusoff A, Ng KY, Lillehei KO. TGF-beta2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors. J Neurooncol. 2007 Jan; 81(2):149-62.
    View in: PubMed
    Score: 0.213
  2. Yang L, Ng KY, Lillehei KO. Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma. Cancer Control. 2003 Mar-Apr; 10(2):138-47.
    View in: PubMed
    Score: 0.167
  3. Liu Y, Ng K, Lillehei KO. Time course analysis and modulating effects of established brain tumor on active-specific immunotherapy. Neurosurg Focus. 2000 Dec 15; 9(6):e3.
    View in: PubMed
    Score: 0.144
  4. Lillehei KO, Liu Y, Kong Q. Current perspectives in immunotherapy. Ann Thorac Surg. 1999 Sep; 68(3 Suppl):S28-33.
    View in: PubMed
    Score: 0.131
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)